Dimensional Fund Advisors LP Atara Biotherapeutics, Inc. Transaction History

Dimensional Fund Advisors LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 09, 2023	SELL	$1.41 - $2.31 $615,198 - $1.01 Million	-436,311 Reduced 66.53%	219,462 $324,000
Q2 2023 Aug 09, 2023	SELL	$1.5 - $3.04 $1.16 Million - $2.36 Million	-776,369 Reduced 54.21%	655,773 $1.06 Million
Q1 2023 May 12, 2023	BUY	$2.8 - $5.46 $1.52 Million - $2.97 Million	543,977 Added 61.25%	1,432,142 $4.15 Million
Q4 2022 Feb 09, 2023	BUY	$2.85 - $5.18 $772,911 - $1.4 Million	271,197 Added 43.96%	888,165 $2.91 Million
Q3 2022 Nov 10, 2022	SELL	$2.85 - $8.73 $1.5 Million - $4.61 Million	-527,988 Reduced 46.11%	616,968 $2.33 Million
Q2 2022 Aug 12, 2022	SELL	$4.69 - $9.84 $915,933 - $1.92 Million	-195,295 Reduced 14.57%	1,144,956 $8.92 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $16.89 $976,854 - $1.95 Million	115,741 Added 9.45%	1,340,251 $12.5 Million
Q4 2021 Feb 09, 2022	BUY	$14.7 - $19.89 $4.61 Million - $6.24 Million	313,582 Added 34.42%	1,224,510 $19.3 Million
Q3 2021 Nov 12, 2021	SELL	$11.99 - $17.9 $5.15 Million - $7.69 Million	-429,817 Reduced 32.06%	910,928 $16.3 Million
Q2 2021 Aug 12, 2021	BUY	$12.89 - $16.58 $1.61 Million - $2.07 Million	124,693 Added 10.25%	1,340,745 $20.8 Million
Q1 2021 May 14, 2021	BUY	$14.0 - $20.72 $4.35 Million - $6.44 Million	310,708 Added 34.32%	1,216,052 $17.5 Million
Q4 2020 Feb 25, 2021	BUY	$12.67 - $26.23 $11.5 Million - $23.7 Million	905,344 New	905,344 $17.8 Million

2.89M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.08B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.